<?xml version="1.0" encoding="UTF-8"?>
<p>The results of our study suggest it is safe and feasible to provide cell therapy with intravenous infusion of bone marrow‚Äêderived MSCs to lung transplant recipients with moderate obstructive CLAD, warranting future studies to assess the effectiveness of this therapy for management of acute or chronic graft dysfunction.</p>
